Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Haemonetics Corp (NY: HAE )

80.07 +1.89 (+2.42%)
Official Closing Price Updated: 7:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 239,911
Open 79.20
Bid (Size) 75.00 (1)
Ask (Size) 88.00 (1)
Prev. Close 78.18
Today's Range 78.35 - 80.15
52wk Range 48.67 - 91.39
Shares Outstanding 51,029,618
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Looking Into Haemonetics's Return On Capital Employed
 
Via Benzinga
Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday
Loop Capital boosted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $120 to $125. Loop Capital analyst Rob Sanderson maintained a Buy rating. Alphabet shares fell 3.7% to $103.70 in pre-market... 
Via Benzinga

Performance

YTD
+3.74%
+3.74%
1 Month
-0.46%
-0.46%
3 Month
+2.04%
+2.04%
6 Month
+3.25%
+3.25%
1 Year
+44.01%
+44.01%

More News

Read More
Incyte, Haemonetics Post Earnings Beats; One Surges Within Buy Zone
Via Investor's Business Daily
Earnings Preview: Haemonetics
Via Benzinga
Where Haemonetics Stands With Analysts
Via Benzinga
How 2022's Biggest Healthcare Gainers Could Fare In 2023
Via MarketBeat
9 Analysts Have This to Say About Haemonetics
Via Benzinga
Watch for Continued Gains in Shares of Haemonetics Corporation (HAE)
Via Investor Brand Network
Where Haemonetics Stands With Analysts
Via Benzinga
Haemonetics: Q1 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold
Via Investor's Business Daily
Analysts Take Bullish Stance On Haemonetics, Cites Plasma Momentum As Catalyst
Via Benzinga
Haemonetics: Q2 Earnings Insights
Via Benzinga
Expert Ratings for Haemonetics
Via Benzinga
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
Via Investor's Business Daily
Cutera Stock Earns Relative Strength Rating Upgrade
Via Investor's Business Daily
Haemonetics Stock Near Buy Zone With EPS Due
Via Investor's Business Daily
Raymond James Thinks Haemonetics Growth Is 'Underappreciated'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Via Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Via Benzinga
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
Via Investor's Business Daily
Haemonetics Surges Closer To A Breakout After Squashing Quarterly Estimates, Raising Guidance
Via Investor's Business Daily
InMode Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
Via Investor's Business Daily
ShockWave Medical Stock Scores Rising Price Performance With Jump To 92 RS Rating
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.